Dr. Kami Maddocks is a Professor of Clinical Internal Medicine and Director of the Lymphoma Program in the Division of Hematology. She specializes in treating patients with B-cell lymphomas. Dr. Maddocks conducts research evaluating new-targeted therapies for these lymphomas, with a particular interest in mantle cell lymphoma and diffuse large B cell lymphoma.
Dr. Maddocks is an investigator on several clinical trials in lymphoma, evaluating non-chemotherapeutic approaches to the treatment of lymphoma and the role of minimal residual disease in predicting outcomes and making therapeutic decisions. She serves on the Alliance Lymphoma Committee, serving as the Alliance Chair on two MCL trials through the AFT and NCTN. In collaboration with colleagues at OSU and Cornell, they were awarded an LLS and NCI P01 to study functional genomics in mantle cell lymphoma therapy and mechanisms of resistance.